Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 07, 2014
The Board of Consort Medical plc, today announced that it has agreed terms to acquire the entire issued and to be issued share capital of Aesica Pharmaceuticals Limited for £230 million. The closing of the transaction, which is expected to occur in ...
read more
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced that is to expand its Shanghai, China, cGMP chemistry and microbiology laboratories to 2000 square meter by Q2 2015 and ...
read more
Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US Food and Drug Administration (FDA).
read more
Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and marketing activities.
read more
CPhI Worldwide, organised by UBM Live, has announced its full line up of confirmed expert industry panel members for 2014, building on the huge success of the CPhI annual report launched at CPhI Worldwide in October 2013.
read more
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, Inc (“CML”), a global leader in pharmaceutical API development ...
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more
Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and...
read more
The Almac Group Ltd, Is pleased to announce plans to make its ALM AADx assay – a gene expression test developed by its Diagnostics Business Unit – available for clinical use in 2015. Further validation of the test in ovarian cancer is on track for ...
read more
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted two additional abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA), which brings the...
read more
As the Industry faces the tightest ever new heavy metal mandates from the FDA, stipulating the control and documentation, where appropriate, of all elemental impurities in drug products, drug substances and excipients, Almac has invested in state of ...
read more
Almac Group Ltd.’s Diagnostics Business Unit today announced the validated results of the ALM AADx assay, a gene expression test that identifies a subgroup of high grade serous ovarian cancer (HGSOC) patients that have a good prognosis following ...
read more
AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC (“OsoBio”) for $110 million in cash. OsoBio is recognized as a premier ...
read more
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its manufacturing subsidiary, Syn-The-All Pharmaceutical ...
read more
Craigavon-based pharmaceutical development company Almac recorded pre-tax profits of £19.2m in 2013, up around 30% on the previous year, it has announced.
read more